Which laboratory finding on CMP is commonly elevated in bone metastases and multiple myeloma?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Study for the Clinical Decision-Making (CDM) Cases Part I Test. Engage with challenging scenarios and questions, complete with hints and explanations for better understanding. Prepare thoroughly for your exam!

Multiple Choice

Which laboratory finding on CMP is commonly elevated in bone metastases and multiple myeloma?

Explanation:
In bone-metastatic disease and multiple myeloma, malignant cells in the bone stimulate osteoclasts and promote bone destruction. As bone tissue is broken down, calcium is released into the bloodstream, leading to elevated serum calcium levels. This pattern shows up on a CMP as hypercalcemia, which is a common metabolic abnormality in these conditions. The other options don’t fit this mechanism: sodium and potassium elevations aren’t characteristically driven by bone destruction, and hypocalcemia would suggest insufficient calcium rather than release from bone.

In bone-metastatic disease and multiple myeloma, malignant cells in the bone stimulate osteoclasts and promote bone destruction. As bone tissue is broken down, calcium is released into the bloodstream, leading to elevated serum calcium levels. This pattern shows up on a CMP as hypercalcemia, which is a common metabolic abnormality in these conditions. The other options don’t fit this mechanism: sodium and potassium elevations aren’t characteristically driven by bone destruction, and hypocalcemia would suggest insufficient calcium rather than release from bone.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy